证券时报e公司讯,沃森生物(300142)在互动平台上表示,公司与艾博生物合作研发的新冠疫苗临床试验在正常推进中。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”